A citation-based method for searching scientific literature

Mariëlle J P van Avendonk, Guy E H M Rutten. Diabetes Obes Metab 2009
Times Cited: 26







List of co-cited articles
165 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Effects of intensive glucose lowering in type 2 diabetes.
Hertzel C Gerstein, Michael E Miller, Robert P Byington, David C Goff, J Thomas Bigger, John B Buse, William C Cushman, Saul Genuth, Faramarz Ismail-Beigi, Richard H Grimm,[...]. N Engl J Med 2008
50

10-year follow-up of intensive glucose control in type 2 diabetes.
Rury R Holman, Sanjoy K Paul, M Angelyn Bethel, David R Matthews, H Andrew W Neil. N Engl J Med 2008
42

Three-year efficacy of complex insulin regimens in type 2 diabetes.
Rury R Holman, Andrew J Farmer, Melanie J Davies, Jonathan C Levy, Julie L Darbyshire, Joanne F Keenan, Sanjoy K Paul. N Engl J Med 2009
446
38

Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes.
Anushka Patel, Stephen MacMahon, John Chalmers, Bruce Neal, Laurent Billot, Mark Woodward, Michel Marre, Mark Cooper, Paul Glasziou, Diederick Grobbee,[...]. N Engl J Med 2008
34





Association between intensification of metformin treatment with insulin vs sulfonylureas and cardiovascular events and all-cause mortality among patients with diabetes.
Christianne L Roumie, Robert A Greevy, Carlos G Grijalva, Adriana M Hung, Xulei Liu, Harvey J Murff, Tom A Elasy, Marie R Griffin. JAMA 2014
116
26

Mortality and other important diabetes-related outcomes with insulin vs other antihyperglycemic therapies in type 2 diabetes.
Craig J Currie, Chris D Poole, Marc Evans, John R Peters, Christopher Ll Morgan. J Clin Endocrinol Metab 2013
132
26

Addition of biphasic, prandial, or basal insulin to oral therapy in type 2 diabetes.
Rury R Holman, Kerensa I Thorne, Andrew J Farmer, Melanie J Davies, Joanne F Keenan, Sanjoy Paul, Jonathan C Levy. N Engl J Med 2007
477
23

Effect of intensive control of glucose on cardiovascular outcomes and death in patients with diabetes mellitus: a meta-analysis of randomised controlled trials.
Kausik K Ray, Sreenivasa Rao Kondapally Seshasai, Shanelle Wijesuriya, Rupa Sivakumaran, Sarah Nethercott, David Preiss, Sebhat Erqou, Naveed Sattar. Lancet 2009
863
23

Insulin-associated weight gain in diabetes--causes, effects and coping strategies.
David Russell-Jones, Rehman Khan. Diabetes Obes Metab 2007
309
23

Glucose control and vascular complications in veterans with type 2 diabetes.
William Duckworth, Carlos Abraira, Thomas Moritz, Domenic Reda, Nicholas Emanuele, Peter D Reaven, Franklin J Zieve, Jennifer Marks, Stephen N Davis, Rodney Hayward,[...]. N Engl J Med 2009
19


Optimal insulin regimens in type 2 diabetes mellitus: systematic review and meta-analyses.
D S Lasserson, P Glasziou, R Perera, R R Holman, A J Farmer. Diabetologia 2009
77
19


Cardiovascular events and all-cause mortality with insulin versus glucagon-like peptide-1 analogue in type 2 diabetes.
Uchenna Anyanwagu, Jil Mamza, Rajnikant Mehta, Richard Donnelly, Iskandar Idris. Heart 2016
25
20


Resistance to insulin therapy among patients and providers: results of the cross-national Diabetes Attitudes, Wishes, and Needs (DAWN) study.
Mark Peyrot, Richard R Rubin, Torsten Lauritzen, Soren E Skovlund, Frank J Snoek, David R Matthews, Rüdiger Landgraf, Line Kleinebreil. Diabetes Care 2005
542
15


Effects of exenatide (exendin-4) on glycemic control over 30 weeks in patients with type 2 diabetes treated with metformin and a sulfonylurea.
David M Kendall, Matthew C Riddle, Julio Rosenstock, Dongliang Zhuang, Dennis D Kim, Mark S Fineman, Alain D Baron. Diabetes Care 2005
900
15



Insulin glargine or NPH combined with metformin in type 2 diabetes: the LANMET study.
H Yki-Järvinen, R Kauppinen-Mäkelin, M Tiikkainen, M Vähätalo, H Virtamo, K Nikkilä, T Tulokas, S Hulme, K Hardy, S McNulty,[...]. Diabetologia 2006
300
15


Initiating insulin therapy in type 2 Diabetes: a comparison of biphasic and basal insulin analogs.
Philip Raskin, Elsie Allen, Priscilla Hollander, Andrew Lewin, Robert A Gabbay, Peter Hu, Bruce Bode, Alan Garber. Diabetes Care 2005
417
15

Basal insulin and cardiovascular and other outcomes in dysglycemia.
Hertzel C Gerstein, Jackie Bosch, Gilles R Dagenais, Rafael Díaz, Hyejung Jung, Aldo P Maggioni, Janice Pogue, Jeffrey Probstfield, Ambady Ramachandran, Matthew C Riddle,[...]. N Engl J Med 2012
988
15

A prospective study of obesity and risk of coronary heart disease among diabetic women.
Eunyoung Cho, JoAnn E Manson, Meir J Stampfer, Caren G Solomon, Graham A Colditz, Frank E Speizer, Walter C Willett, Frank B Hu. Diabetes Care 2002
73
15

Management of hyperglycemia in type 2 diabetes, 2015: a patient-centered approach: update to a position statement of the American Diabetes Association and the European Association for the Study of Diabetes.
Silvio E Inzucchi, Richard M Bergenstal, John B Buse, Michaela Diamant, Ele Ferrannini, Michael Nauck, Anne L Peters, Apostolos Tsapas, Richard Wender, David R Matthews. Diabetes Care 2015
15

Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes.
Steven P Marso, Gilbert H Daniels, Kirstine Brown-Frandsen, Peter Kristensen, Johannes F E Mann, Michael A Nauck, Steven E Nissen, Stuart Pocock, Neil R Poulter, Lasse S Ravn,[...]. N Engl J Med 2016
15


One-year treatment with exenatide improves beta-cell function, compared with insulin glargine, in metformin-treated type 2 diabetic patients: a randomized, controlled trial.
Mathijs C Bunck, Michaela Diamant, Anja Cornér, Bjorn Eliasson, Jaret L Malloy, Rimma M Shaginian, Wei Deng, David M Kendall, Marja-Riitta Taskinen, Ulf Smith,[...]. Diabetes Care 2009
303
11


Psychological insulin resistance in patients with type 2 diabetes: the scope of the problem.
William H Polonsky, Lawrence Fisher, Susan Guzman, Leonel Villa-Caballero, Steven V Edelman. Diabetes Care 2005
368
11

Exenatide versus insulin glargine in patients with suboptimally controlled type 2 diabetes: a randomized trial.
Robert J Heine, Luc F Van Gaal, Don Johns, Michael J Mihm, Mario H Widel, Robert G Brodows. Ann Intern Med 2005
600
11


Improvement of glycemic control in subjects with poorly controlled type 2 diabetes: comparison of two treatment algorithms using insulin glargine.
Melanie Davies, Fred Storms, Simon Shutler, Monique Bianchi-Biscay, Ramon Gomis. Diabetes Care 2005
226
11

Insulin therapy in type 2 diabetes is no longer a secondary care activity in the Netherlands.
Mariëlle J P van Avendonk, Kees J Gorter, Maureen van den Donk, Guy E H M Rutten. Prim Care Diabetes 2009
17
17


Lower within-subject variability of insulin detemir in comparison to NPH insulin and insulin glargine in people with type 1 diabetes.
Tim Heise, Leszek Nosek, Birgitte Biilmann Rønn, Lars Endahl, Lutz Heinemann, Christoph Kapitza, Eberhard Draeger. Diabetes 2004
409
11




Use of twice-daily exenatide in Basal insulin-treated patients with type 2 diabetes: a randomized, controlled trial.
John B Buse, Richard M Bergenstal, Leonard C Glass, Cory R Heilmann, Michelle S Lewis, Anita Y M Kwan, Byron J Hoogwerf, Julio Rosenstock. Ann Intern Med 2011
389
11

Statement by an American Association of Clinical Endocrinologists/American College of Endocrinology consensus panel on type 2 diabetes mellitus: an algorithm for glycemic control.
Helena W Rodbard, Paul S Jellinger, Jaime A Davidson, Daniel Einhorn, Alan J Garber, George Grunberger, Yehuda Handelsman, Edward S Horton, Harold Lebovitz, Philip Levy,[...]. Endocr Pract 2009
678
11

Clinical outcomes after insulin initiation in patients with type 2 diabetes: 6-month data from the INSTIGATE observational study in five European countries.
Andreas Liebl, Stephen Jones, Marian Benroubi, Conxa Castell, Albert Goday, Marie Aline Charles, Helen T Smith, Claudia Nicolay, Alexander Simpson. Curr Med Res Opin 2011
24
12


Efficacy of insulin analogs in achieving the hemoglobin A1c target of <7% in type 2 diabetes: meta-analysis of randomized controlled trials.
Dario Giugliano, Maria Ida Maiorino, Giuseppe Bellastella, Paolo Chiodini, Antonio Ceriello, Katherine Esposito. Diabetes Care 2011
93
11

Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study.
I M Stratton, A I Adler, H A Neil, D R Matthews, S E Manley, C A Cull, D Hadden, R C Turner, R R Holman. BMJ 2000
11


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.